RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. FCF margin (%)

Edwards Lifesciences CorpEW

Market cap
$50.9B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 20245.3-50.21%
Dec 31, 202310.7-40.82%
Dec 31, 202218.1-32.70%
Dec 31, 202126.9+82.12%
Dec 31, 202014.8-30.63%
Dec 31, 201921.3+15.10%
Dec 31, 201818.5-23.74%
Dec 31, 201724.2+35.96%
Dec 31, 201617.8-0.55%
Dec 31, 201517.9-55.68%
Dec 31, 201440.4+127.44%
Dec 31, 201317.8+33.45%
Dec 31, 201213.3-3.43%
Dec 31, 201113.8+5.30%
Dec 31, 201013.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)